S100A11 has been shown to play a dual role in tumors, such as inhibiting cancer of the bladder and kidney or promoting cancer of the pancreas (Yao et al., 2007; Donato et al., 2013; Gross et al., 2014; Bresnick et al., 2015). Here, S100A11 is linked to urinary bladder carcinoma.